IMCT-17STATISTICALLY SIGNIFICANT ASSOCIATION OF GLIOBLASTOMA IMMUNOTHERAPY PHASE II CLINICAL STUDY (ICT-107) TREATMENT AND SURVIVAL TO IMMUNE RESPONSE USING A NOVEL COMPREHENSIVE ELISPOT ANALYSIS

Saved in:
Bibliographic Details
Published inNeuro-oncology (Charlottesville, Va.) Vol. 17; no. suppl 5; pp. v111.2 - v111
Main Authors Santos, Radleigh, Gringeri, Anthony, Yu, John, Janetzki, Sylvia, Judkowski, Valeria, Pinilla, Clemencia
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.11.2015
Subjects
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Online AccessGet full text

Cover

More Information
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/nov218.17